These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 33663112)
1. Novel oxidative stress-related prognostic biomarkers for melanoma associated with tumor metastasis. Wu X; Zhao J Medicine (Baltimore); 2021 Feb; 100(8):e24866. PubMed ID: 33663112 [TBL] [Abstract][Full Text] [Related]
2. Identification of hub prognosis-associated oxidative stress genes in skin cutaneous melanoma using integrated bioinformatic analysis. Ren TY; Zhang YX; Hu W Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):2927-2940. PubMed ID: 33877656 [TBL] [Abstract][Full Text] [Related]
3. The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma. Huang R; Li M; Zeng Z; Zhang J; Song D; Hu P; Yan P; Xian S; Zhu X; Chang Z; Zhang J; Guo J; Yin H; Meng T; Huang Z Cancer Control; 2022; 29():10732748211051554. PubMed ID: 34986671 [TBL] [Abstract][Full Text] [Related]
4. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma. Liu X; Wang J Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma. Tian Q; Gao H; Zhao W; Zhou Y; Yang J Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650 [TBL] [Abstract][Full Text] [Related]
6. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature. Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392 [TBL] [Abstract][Full Text] [Related]
7. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM. Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y Front Immunol; 2024; 15():1387316. PubMed ID: 38660305 [TBL] [Abstract][Full Text] [Related]
8. Construction of autophagy prognostic signature and analysis of prospective molecular mechanisms in skin cutaneous melanoma patients. Liao S; He J; Liu C; Zhang Z; Liao H; Liao Z; Yu C; Guan J; Mo H; Yuan Z; Liang T; Lu Z; Xu G; Wang Z; Chen J; Jiang J; Zhan X Medicine (Baltimore); 2021 Jun; 100(22):e26219. PubMed ID: 34087900 [TBL] [Abstract][Full Text] [Related]
9. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma. Fan Y; Liang X; Yu D Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934 [TBL] [Abstract][Full Text] [Related]
10. RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous Melanoma. Liu M; Bai R; Zhang G; Liu X; Wang Z; He K; Gan X; Zhou X; Yin P; Zheng Y; Wang G Sci Rep; 2024 Jun; 14(1):14113. PubMed ID: 38898266 [TBL] [Abstract][Full Text] [Related]
11. Prognostic and immune-related value of STK17B in skin cutaneous melanoma. Shi X; Zhou Q; Huang B; Xia S; Jiang Y; Fang S; Lin J PLoS One; 2022; 17(2):e0263311. PubMed ID: 35171924 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of an oxidative stress-associated prognostic risk model for melanoma. Yang Y; Long X; Li K; Li G; Yu X; Wen P; Luo J; Tian X; Zhao J PeerJ; 2021; 9():e11258. PubMed ID: 33976978 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of aberrantly methylated differentially expressed genes and validation of CDC6 in melanoma. Liao L; Han W; Shen Y; Shen G J Cancer Res Clin Oncol; 2024 Jul; 150(7):362. PubMed ID: 39052109 [TBL] [Abstract][Full Text] [Related]
14. Prognostic score model-based signature genes for predicting the prognosis of metastatic skin cutaneous melanoma. Wang J Math Biosci Eng; 2021 Jun; 18(5):5125-5145. PubMed ID: 34517481 [TBL] [Abstract][Full Text] [Related]
15. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma. Zhao S; Zhu Y; Liu H; He X; Xie J J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289 [TBL] [Abstract][Full Text] [Related]
16. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment. Han W; Huang B; Zhao XY; Shen GL Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma. Jiang Y; Zhang C; Zhang J; Han D; Shi X Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma. Yang RH; Liang B; Li JH; Pi XB; Yu K; Xiang SJ; Gu N; Chen XD; Zhou ST J Cell Mol Med; 2021 Dec; 25(23):10990-11001. PubMed ID: 34755462 [TBL] [Abstract][Full Text] [Related]
19. Gene expression and immune infiltration in melanoma patients with different mutation burden. Wang L; Chen F; Liu R; Shi L; Zhao G; Yan Z BMC Cancer; 2021 Apr; 21(1):379. PubMed ID: 33836680 [TBL] [Abstract][Full Text] [Related]
20. Screening of gene markers related to the prognosis of metastatic skin cutaneous melanoma based on Logit regression and survival analysis. Jia G; Song Z; Xu Z; Tao Y; Wu Y; Wan X BMC Med Genomics; 2021 Apr; 14(1):96. PubMed ID: 33823876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]